Log In
BCIQ
Print this Print this
 

SCIPE (FAVORITE-delivered budesonide) (VR647)

  Manage Alerts
Collapse Summary General Information
Company Vectura Group plc
DescriptionBudesonide, a corticosteroid, delivered using Activaero's FAVORITE inhalation delivery technology
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAsthma
Indication DetailsTreat mild to moderate asthma in children
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$188.9M

$111.1M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/13/2014

$188.9M

$111.1M

0

Get a free BioCentury trial today